Ideas
Bi-annual market review & outlook
Bi-annual market review & outlook
The growing market for GLP 1 DRUGSAs obesity rates swell worldwide, popular GLP-1 (Glucagon-like peptide-1) drugs such as Ozempic and Wegovy have generated investor interest. Demand for these drugs has outstripped supply and companies such as Novo Nordisk and Eli Lilly have a strong hold on the market share. Investors should also consider the broader market opportunities and cross-sector implications of GLP-1 drugs.
Discover the Sustainable Ocean Fund 2023 Impact Report.
Discover the 2023 impact report of our energy transition infrastructure platform.
Discover the 2023 impact report of our energy transition infrastructure platform.
Monthly market review and outlook
Monthly market review and outlook